Directors Shareholding

RNS Number : 2232J

Hutchison China Meditech Limited

01 April 2015

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Directors' Shareholding

London: Wednesday, 1 April 2015: Chi-Med received notifications on 1 April 2015 that the following Directors have purchased ordinary shares of US$1.00 each in Chi-Med (the "Shares") as follows:-

Director	Date of purchase	Number of Shares purchased	Purchase price	Beneficial interest in Shares following purchases
				Number of Shares	% of total issued share capital
Simon To (Executive Director and Chairman)	30 March 2015 1 April 2015	13,000 15,000	GBP13.00 GBP13.65	69,000	0.13%
Edith Shih (Non-executive Director and Company Secretary)	30 March 2015 1 April 2015	13,000 15,000	GBP13.00 GBP13.65	48,000	0.09%

Ends

Enquiries

Chi-Med	Telephone:        [phone]
Christian Hogg, CEO
Panmure Gordon (UK) Limited	Telephone:        [phone]
Richard Gray
Andrew Potts
Citigate Dewe Rogerson	Telephone:        [phone]
Anthony Carlisle	Mobile:             [phone]
David Dible	Mobile:             [phone]

About Chi-Med

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 

END

 

 

RDSPKDDQQBKDQQK